Elanco Animal Health (ELAN) Tops Q3 EPS by 1c, Offers Q4 Guidance

Elanco Animal Health (NYSE: ELAN) reported Q3 EPS of $0.13, $0.01 better than the analyst estimate of $0.12. Revenue for the quarter came in at $889.6 million versus the consensus estimate of $909.34 million.

GUIDANCE:

Elanco Animal Health sees Q4 2020 revenue of $1.02-1.06 billion, versus the consensus of $1.09 billion.

For earnings history and earnings-related data on Elanco Animal Health (ELAN) click here.

You May Also Be Interested In

• SanDisk stock target lifted at Bernstein to $3000 on new memory LTAs
• Conduent to sell tolling unit to Quarterhill for $70 million
• Air Products cancels Louisiana clean energy project, faces $2.9B charge